as on January 28, 2026 at 2:29 am IST
Day's Low
Day's High
4.01%
Downside
2.07%
Upside
52 Week's Low
52 Week's High
83.19%
Downside
13.06%
Upside
Check Amylyx Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.6B
EPS (TTM)
-1.5274
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.87
Industry PE ratio
-2.8168481375358168
PEG Ratio
0EBITDA
-193.0M
Revenue (TTM)
-665.0K
Profit Margin
0.00%
Return On Equity TTM
-56.53%
Track how Amylyx Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Amylyx Pharmaceuticals, Inc. in the last 5 years
Lowest (-21.78x)
June 30, 2023
Industry (-2.82x)
January 28, 2026
Today (-0.87x)
January 28, 2026
Highest (23.35x)
March 31, 2024
Today’s Price to Earnings Ratio: -0.87x
Compare market cap, revenue, PE, and other key metrics of Amylyx Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.6B | NA | -0.87 | 0.00% | |
| NA | $14.4B | NA | NA | 0.00% | |
| BUY | $21.6B | NA | 18.08 | 40.65% | |
| BUY | $46.2B | NA | 22.54 | 13.81% | |
| HOLD | $15.2B | -23.68% | -21.95 | -26.13% |
The Amylyx Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Amylyx Pharmaceuticals, Inc. investment value today
Current value as on today
₹4,54,380
Returns
₹3,54,380
(+354.38%)
Returns from Amylyx Pharmaceuticals, Inc. Stock
₹3,48,406 (+348.41%)
Dollar Returns*
₹5,974 (+5.97%)
Based on 13 analysts
53.85%
Buy
46.15%
Hold
0.00%
Sell
Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Amylyx Pharmaceuticals, Inc.. Average target price of $20.22
Get share price movements and forecasts by analysts on Amylyx Pharmaceuticals, Inc..
What analysts predicted
23.49%UPSIDE
Target Price
$20.22
Current Price
$15.47
Analyzed by
13 Analysts
Target
$20.22
Amylyx Pharmaceuticals, Inc. target price $20.22, a slight upside of 23.49% compared to current price of $15.47. According to 13 analysts rating.
Search interest for Amylyx Pharmaceuticals, Inc. Stock has increased by 108% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:108% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -41.44M → -34.38M (in $), with an average increase of 20.5% per quarter
Against Peers
![]()
In the last 1 year, Regencell Bioscience Holdings Ltd has given 28567.3% return, outperforming this stock by 28218.9%
Against Peers
![]()
In the last 3 years, Regencell Bioscience Holdings Ltd has given 3962.6% return, outperforming this stock by 4024.8%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 416.0K → -665.0K (in $), with an average decrease of 259.9% per quarter
Price Dip
![]()
In the last 7 days, AMLX stock has moved down by -8.6%
| Organisation | Amylyx Pharmaceuticals, Inc. |
| Headquarters | 43 Thorndike Street, Cambridge, MA, United States, 02141 |
| Industry | Services |
| CEO | Mr. Joshua B. Cohen |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Linda A. Arsenault | Chief Human Resources Officer |
Mr. Joshua B. Cohen | Co-Founder, Co-CEO & Director |
Mr. Justin B. Klee | Co-Founder, Co-CEO & Director |
Mr. James M. Frates M.B.A. | Chief Financial Officer |
Ms. Tammy Sarnelli | Global Head of Regulatory Affairs |
Dr. Machelle Manuel Ph.D. | VP & Head of Global Medical Affairs |
Dr. Jamie Timmons | Head of Global Medical Strategy & Communications |
Ms. Gina M. Mazzariello J.D. | Chief Legal Officer & General Counsel |
Mr. Tom Holmes | Chief Technical Operations Officer |
Ms. Lindsey Allen | Head of Investor Relations & Communications |
Amylyx Pharmaceuticals, Inc. share price today is $15.47 as on at the close of the market. Amylyx Pharmaceuticals, Inc. share today touched a day high of $15.79 and a low of $14.85.
Amylyx Pharmaceuticals, Inc. share touched a 52 week high of $17.49 on and a 52 week low of $2.6 on . Amylyx Pharmaceuticals, Inc. stock price today i.e. is closed at $15.47,which is 11.55% down from its 52 week high and 495.00% up from its 52 week low.
Amylyx Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Amylyx Pharmaceuticals, Inc. (AMLX) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Amylyx Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amylyx Pharmaceuticals, Inc. share’s latest price of $15.47 as on January 28, 2026 at 2:29 am IST, you will get 0.6464 shares of Amylyx Pharmaceuticals, Inc.. Learn more about
fractional shares .